Risk Factors for Esophageal Candidiasis in Non-HIV Patients: A Systematic Review

  • Muhammad Faisal Prananda Division of Gastroenterology, Pancreatobiliary and Digestive Endoscopy, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
  • Kemal Akbar Suryoadji Research Assistant, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
  • Najma Ali Medical Profession Student, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
  • Rania Sofia Garnetta Medical Profession Student, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
  • Achmad Fauzi Division of Gastroenterology, Pancreatobiliary and Digestive Endoscopy, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
  • Dadang Makmun Division of Gastroenterology, Pancreatobiliary and Digestive Endoscopy, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
Keywords: corticosteroids, esophageal candidiasis, non-HIV, proton pump inhibitors, risk factors

Abstract

Esophageal candidiasis is commonly associated with HIV infection but also occurs in patients without HIV. This systematic review aimed to summarize risk factors for esophageal candidiasis in non-HIV patients. PubMed, the Cochrane Library, and ScienceDirect were searched for studies evaluating risk factors in non-HIV populations or reporting non-HIV subgroups separately, and the findings were synthesized qualitatively. Four studies met the inclusion criteria, comprising retrospective case–control and prospective observational studies in endoscopy-based settings. Reported prevalence among non-HIV patients ranged from 0.34% to 8.99%, depending on the population and case ascertainment. Corticosteroid use was the most consistently reported risk factor (odds ratios 2.05 to 6.67), and one study found a higher risk with higher doses. Proton pump inhibitor use (odds ratio 1.66), broad-spectrum antibiotic exposure (4.55), diabetes mellitus (7.34), malignancy (8.05), and increasing age (1.02 per year) were also reported, but proton pump inhibitor use and diabetes mellitus were significant in one study and not in another. Dysphagia and odynophagia predicted esophageal candidiasis in one prospective study, whereas a retrospective study found no correlation between symptoms and endoscopic severity. Corticosteroid exposure is the most consistent risk factor for esophageal candidiasis in non-HIV patients. Prospective multicenter studies with standardized definitions are needed to clarify the other associations.

Downloads

Download data is not yet available.

References

Kimchy, A. V., Ahmad, A. I., Tully, L., Lester, C., Sanghavi, K., & Jennings, J. J. (2023). Prevalence and clinical risk factors for esophageal candidiasis in non-human immunodeficiency virus patients: A multicenter retrospective case-control study. World Journal of Gastrointestinal Endoscopy, 15(6), 480-490. https://doi.org/10.4253/wjge.v15.i6.480

Tan, X. T., Abdul Rahman, S. H. B., Low, L. L., & Binti Ma’amor, N. H. (2026). Prevalence and risk factors for oropharyngeal, esophageal, and oral candidiasis in HIV-positive individuals: A systematic review and meta-analysis. Interdisciplinary Perspectives on Infectious Diseases, 2026, 6445594. https://doi.org/10.1155/ipid/6445594

Takahashi, Y., Nagata, N., Shimbo, T., Nishijima, T., Watanabe, K., Aoki, T., Sekine, K., Okubo, H., Watanabe, K., Sakurai, T., Yokoi, C., Kobayakawa, M., Yazaki, H., Teruya, K., Gatanaga, H., Kikuchi, Y., Mine, S., Igari, T., Takahashi, Y., . . . Uemura, N. (2015). Long-term trends in esophageal candidiasis prevalence and associated risk factors with or without HIV infection: Lessons from an endoscopic study of 80,219 patients. PLOS ONE, 10(7), e0133589. https://doi.org/10.1371/journal.pone.0133589

Nabiei, F., Samimi, R., Nasirian, N., Mirzadeh, M., Badri, M., & Mohammadi, F. (2026). Candida colonization and esophagitis in HIV-negative patients: An endoscopic, histopathological, and molecular study. Canadian Journal of Infectious Diseases and Medical Microbiology, 2026, 2877787. https://doi.org/10.1155/cjid/2877787

Yakoob, J., Jafri, W., Abid, S., Jafri, N., Islam, M., Hamid, S., Shah, H. A., & Hussainy, A. S. (2003). Candida esophagitis: Risk factors in non-HIV population in Pakistan. World Journal of Gastroenterology, 9(10), 2328-2331. https://doi.org/10.3748/wjg.v9.i10.2328

Rodrigues, S., Leitão Esteves, V., & Martins, T. G. (2022). Esophageal candidiasis in a non-HIV patient: A primary care diagnosis. Cureus, 14(4), e24312. https://doi.org/10.7759/cureus.24312

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., . . . Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71

Wells, G. A., Shea, B., O’Connell, D., Peterson, J., Welch, V., Losos, M., & Tugwell, P. (n.d.). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp

Modesti, P. A., Reboldi, G., Cappuccio, F. P., Agyemang, C., Remuzzi, G., Rapi, S., Perruolo, E., Parati, G., & ESH Working Group on CV Risk in Low Resource Settings. (2016). Panethnic differences in blood pressure in Europe: A systematic review and meta-analysis. PLOS ONE, 11(1), e0147601. https://doi.org/10.1371/journal.pone.0147601

Mushi, M. F., Ngeta, N., Mirambo, M. M., & Mshana, S. E. (2018). Predictors of esophageal candidiasis among patients attending endoscopy unit in a tertiary hospital, Tanzania: A retrospective cross-sectional study. African Health Sciences, 18(1), 66-71. https://doi.org/10.4314/ahs.v18i1.10

Ou, T.-M., Huang, H.-H., Hsieh, T.-Y., Chang, W.-K., Chu, H.-C., Hsu, C.-H., Shih, Y.-L., Huang, T.-Y., Chen, P.-J., & Lin, H.-H. (2014). Liver cirrhosis as a predisposing factor for esophageal candidiasis. Advances in Digestive Medicine, 1(3), 86-91. https://doi.org/10.1016/j.aidm.2013.09.005

Takahashi, Y., Nagata, N., Shimbo, T., Nishijima, T., Watanabe, K., Aoki, T., Sekine, K., Okubo, H., Watanabe, K., Sakurai, T., Yokoi, C., Mimori, A., Oka, S., Uemura, N., & Akiyama, J. (2015). Upper gastrointestinal symptoms predictive of Candida esophagitis and erosive esophagitis in HIV and non-HIV patients: An endoscopy-based cross-sectional study of 6011 patients. Medicine, 94(47), e2138. https://doi.org/10.1097/MD.0000000000002138

Lionakis, M. S., & Kontoyiannis, D. P. (2003). Glucocorticoids and invasive fungal infections. The Lancet, 362(9398), 1828-1838. https://doi.org/10.1016/S0140-6736(03)14904-5

Li, Z., & Denning, D. W. (2023). The impact of corticosteroids on the outcome of fungal disease: A systematic review and meta-analysis. Current Fungal Infection Reports, 17(1), 54-70. https://doi.org/10.1007/s12281-023-00456-2

Shi, Y., Li, J., Cai, S., Zhao, H., Zhao, H., Sun, G., & Yang, Y. (2023). Proton pump inhibitors induced fungal dysbiosis in patients with gastroesophageal reflux disease. Frontiers in Cellular and Infection Microbiology, 13, 1205348. https://doi.org/10.3389/fcimb.2023.1205348

Batista, A. O., Nascimento, W. V., Cassiani, R. A., Silva, A. C. V., Alves, L. M. T., Alves, D. C., & Dantas, R. O. (2020). Prevalence of non-obstructive dysphagia in patients with heartburn and regurgitation. Clinics, 75, e1556. https://doi.org/10.6061/clinics/2020/e1556

Published
2026-12-01
How to Cite
Muhammad Faisal Prananda, Suryoadji, K. A., Najma Ali, Rania Sofia Garnetta, Achmad Fauzi, & Dadang Makmun. (2026). Risk Factors for Esophageal Candidiasis in Non-HIV Patients: A Systematic Review. Jurnal Kesehatan Cendikia Jenius , 4(1), 6-14. https://doi.org/10.70920/jenius.v4i1.482